Exosome Research

Exosomes are a type of extracellular vesicle (EV) with a diameter of 30-100 nm released from cells. It contains nucleic acids (mRNA, microRNA) and proteins, and there is increasing interest in its role as a tool in intercellular communication and its use as a biomarker in various diseases including cancer. However, exosome experimental technology is still under development and there are many issues.

In collaboration with Professor Hanayama (Department of Immunology, Kanazawa University Graduate School of Medical Sciences), Fujifilm Wako established a "PS affinity method" using Tim4, a protein that binds phosphatidylserine (PS) present on the surface of exosomes in a calcium ion-dependent manner. We have developed an exosome isolation kit. This kit enables the isolation of exosomes with high purity and less damage compared to conventional methods.

Fujifilm Wako can offer the solution of EV research!

Research process and product lineup
Process
Production
Isolation/ Purification
Detection/ Determination
Analysis
Overview Cultured cells release exosomes. The amount of production varies depending on the medium. Isolated and purified from culture supernatants or body fluid samples. The purity and recovery amount differ depending on the method. Exosomes are detected and quantified using exosome surface marker protein etc. Analyze nucleic acids (miRNA and mRNA), proteins, lipids, etc. included in exosomes.
Product Culture Media
Culture Plate
Purified Exosome
Isolation Kits (★)
Blocking Reagents
ELISA Kits (★)
Flow Cytometry Kits (★)
Antibodies
RNA Isolation Kits

★: Contains products based on "PS affinity method"

Exosome_Ondemand_Webinar_Webpage_LowBanner.png

banner_exosome_guidebook_EN.png

Exosome_Application_Note_img01.png

Exosome_Technical_Report_img01.png

More Information

What are Exosomes?
Rikinari Hanayama Professor, Department of Immunology, Kanazawa University Graduate School of Medical Sciences

  In recent years, research of extracellular vesicles (EVs) has been advancing at an accelerating pace. While the number of scientific articles on EVs published in 2011 was approximately two hundred, the number increased to more than one thousand in 2016 and involvement of EVs in various physiological functions and pathogenic mechanisms has been suggested. Although EVs are roughly classified into at least two categories: exosomes derived from endosomes and microvesicles derived from the plasma membrane, it is difficult to strictly separate them from each other by differential centrifugation, the technique most frequently used for purification of EVs at present, and the EVs not sedimenting at 10,000×g are called "small EVs" (mainly composed of exosomes) for convenience.1)
  Exosomes are small membrane vesicles (approximately 30-100 nm in diameter) secreted by various cells and present in most body fluids (e.g., blood, urine, and spinal fluid) and cell culture liquids. Exosomes, membrane vesicles surrounded by a lipid bilayer, are generated within intracellular vesicles called "multi-vesicular endosomes" and released into the extracellular space by fusion of multi-vesicular endosomes with the cell membrane. Exosomes contain proteins from secretory cells, including those of endosome origin (e.g., ESCRTs), those involved in intracellular transport (e.g., Rab GTPase), and those of cell membrane origin (e.g., CD63 and CD81), as well as RNAs. Exosomes also contain the cell membrane of secretory cells and lipids from the endosome membrane (cholesterol and sphingomyelin, etc.).2)
  Although exosomes had long been considered to be involved in release of unnecessary cell contents, exosomes are recently attracting attentions of researchers as new mediators of cell-cell communication transporting biomolecules such as lipids, proteins, and RNAs in vivo. In addition to clarifi cation of physiological or pathophysiological functions of exosomes, research aiming at clinical application of these functions is rapidly in progress, particularly focusing on diagnostic and therapeutic application as well as development of biomarkers.

  Current exosome research covers almost all research areas in biomedical science (immunology, neuroscience, oncology, endocrinology, and cardiovascular research). For example, exosomes derived from immune cells have been shown to contain antigen peptide/MHC complexes and various antigens, which suggests a possibility that exosomes might regulate various immune responses such as activation/inactivation of immune cells in addition to the exchange of antigenic information between immune cells.3) In the nervous system, exosomes have been found to be involved not only in regulation of neural circuits4) but also in extracellular release of proteins causing various neurodegenerative diseases for subsequent transmission to other cells, a process that might be deeply involved in disease progression.5) Exosomes released by cancer cells contain many biomolecules related to angiogenesis and immune evasion, suggesting that they might contribute to construction of microenvironment optimal for cancer cell growth and promotion of cancer progression.6) In addition, the expression profile of adhesion molecules on the surface of exosomes from cancer cells has been shown to determine the destination of cancer metastasis.7) Recently, exosomes released from adipocytes have been reported to regulate gene expression in the liver.8) Furthermore, while many viruses leave cells by utilizing the pathway for exosome production, bacteria and parasites infecting cells are likely to regulate activities of bacteria/parasites infecting other cells via exosomes.9, 10) Most of the above-mentioned functions are mediated by secretory cell-derived biomolecules located within exosomes. In particular, since mRNAs and miRNAs of secretory cell origin were identified in exosomes, potential involvement of exosomes in horizontal transmission of gene expression information between cells has been attracting great research interest.11) Since these RNAs are encapsulated within the lipid bilayer membrane of exosomes, they are not susceptible to degradation by RNase and remain intact in blood or other body fluid. Exosomes incorporated into target cells fuse with the endosome membrane to release encapsulated RNAs into the cytosol of target cells. Once released into the cytosol, mRNAs are translated into proteins while miRNAs suppress translation of target genes. Thus, exosomes regulate gene expression within target cells. A single exosome is considered to contain more than several ten-thousands of proteins and more than several thousands of mRNAs and miRNAs. The composition of these biomolecules may vary depending on the type and conditions of a secretory cell which originally harbored the exosome. In addition, the composition of proteins, mRNAs, and miRNAs within an exosome is different from that within the original secretory cell, which suggests the existence of a mechanism selectively loading exosome- specific proteins and mRNAs/miRNAs into exosomes. Such specific composition of exosome RNAs makes them attractive candidates for biomarkers and targets for therapeutic development. While mRNAs within exosomes incorporated into target cells are capable of inducing expression of functional proteins, most miRNA within exosomes are present as precursors of functional miRNA and their physiological significance is under extensive investigation. Thus, since exosomes contain a wide variety of proteins, RNAs, and lipids, construction of an exosome database "ExoCarta" is currently ongoing through claassification by cell types. Furthermore, while large scale analysis of exosomes utilizing cutting-edge methodologies in proteomics, transcriptomics, and system biology are separately conducted in laboratories all over the world, EV plugin for FunRich (a stand-alone functional enrichment analysis tool) is distributed aiming at a common and integrated analysis tool. Sharing information among researchers in a wide variety of research fields is essential for promotion of future exosome research.

Development of exosome-based therapeutic/diagnostic methods

  In parallel with clarification of exosome functions, efforts to develop therapeutic methods applying exosome functions are being continued in recent years. For example, exosomes released from blood fibrocytes (a population of mesenchymal progenitors) accelerate wound healing by stimulating angiogenesis and inducing migration and proliferation of keratinocytes. Proangiogenic, anti-inflammatory miRNAs as well as a miRNA promoting collagen deposition within these exosomes are reportedly involved in this process.12) In addition, exosomes released from dendritic cells in patients with cancer contain a variety of cancer cell-derived proteins and induce intense activation of cancer cell-specific cytotoxic T lymphocytes. Development of cancer immunotherapy based on this mechanism is currently in the early phase of clinical research.13) On the other hand, suppression of exosomal functions involved in pathogenesis has also been attempted. For example, apoptosis- inducing TNF-α is accumulated at high concentrations in exosomes released from synovial fibroblasts in patients with rheumatoid arthritis and exacerbates the pathology of rheumatoid arthritis.14) In addition, since cancer cellderived exosomes contain molecules related to cancer progression and neuron-derived exosomes contain molecules related to neurodegenerative diseases as described above, inhibition or removal of these exosomes may potentially suppress onset of these diseases. Advancement of future research is expected to clarify exosome functions and expand indications of clinically applied exosomes, thereby realizing utilization of exosomes for the treatment of various diseases. Furthermore, delivery of drugs such as siRNAs and anticancer agents to target cells using exosomes has been attempted. Since various cell adhesion molecules are expressed on the surface of exosome membrane and the expression profile of these molecules has been found to determine the target cells for exosome delivery, application of this property to development of a new drug delivery system (DDS) is expected.15) Exosomes are extremely stable in body fluids, and the exosome lipid bilayer membrane encapsulating proteins and RNAs within vesicles protects them from degradation. Furthermore, exosomes remain relatively intact even in body fluid specimens stored for a long time after collection and are therefore considered as new and promising laboratory biomarkers for diseases. While correlations between exosomes and various diseases have been investigated, cancer cell-derived exosomes released into blood are recently attracting research interest due to difference in constituents from normal cell-derived exosomes and a correlation between constituents of cancer cell-derived exosomes and cancer progression has been extensively investigated as a potential tool for early cancer diagnosis.16) In addition, exosomes in urine are expected as a new diagnostic marker for renal, prostate, and bladder diseases, while exosomes in cerebrospinal fluid as a new marker for brain tumor and neurodegenerative diseases.

Issues and future perspectives of exosome research

  Although many studies on roles of exosomes have already been reported, experiments providing evidence for these reported phenomena use highly concentrated exosomes purified from body fluids and cell culture supernatants. Accordingly, whether these phenomena actually occur in vivo remains unclear. The sole approach for clarification of physiological actions of exosomes is to clarify the mechanism of exosome release and physiological phenomena induced by exosome release stimulation/inhibition through modulating the mechanism, which is expected to result in further advancement in exosome research. Another important issue to be addressed in future research and development is in vivo kinetics of exosomes (i.e., which exosomes are directed to which target cells). Conventional methods for exosome purification mainly involved ultracentrifugation and various commercial purification kits using polyethylene glycol (PEG) precipitation technique. However, exosome preparations obtained by these methods contain large amounts of contaminants and careful analysis is required to determine whether experimental results obtained are actually due to actions of exosome constituents per se. Furthermore, ultracentrifugation requiring cumbersome manipulation has several disadvantages including inconsistent recovery interfering quantitative analysis and requirement for an expensive instrument not compatible with high-throughput analysis. Conducting exosome research under these circumstances is difficult and development of technology for easy purification of exosomes at a high purity is urgently needed. We focused on Tim4, an exosome receptor expressed on macrophages, and prepared "Tim4 magnetic beads" by immobilizing the extracellular region of Tim4 on magnetic beads.17) Since Tim4 binds to phosphatidylserine (PS), a phospholipid on the surface of exosome membrane, in a calcium ion-dependent manner, bound exosomes are released from these beads with an elution buffer containing ethylenediaminetetraacetic acid (EDTA), a chelating agent, to obtain highly purified intact exosomes. In fact, when exosomes released from human leukemia cells were purified by the Tim4-affinity method and compared for purity with exosomes purified by ultracentrifugation and PEG precipitation, the Tim4-affinity method yielded exosome preparations with exosome-specific proteins each exhibiting a band intensity over 10-100 times higher than that obtained by other methods and almost free from non-exosome contaminants, thereby demonstrating reproducible recovery of high-purity exosomes. As a result, many previously unidentified exosome proteins and RNAs could be identified from exosome preparations obtained by this method. Furthermore, application of the strong binding affinity of Tim4 toward exosomes realized high-sensitivity detection and assay of exosomes by enzyme-linked immunosorbent assay (ELISA) and fluorescence-activated cell sorting (FACS). On the other hand, while only crude preparations of microvesicles were conventionally obtained because differential centrifugation was the sole purification technique available, the Tim4-affinity method realized purification of microvesicles at a high purity as well. Details of these techniques are described in this guidebook. We expect that usefulness of these Tim4-affinity-based techniques will be appreciated in the world and greatly contribute to clarification of the original physiological functions of exosomes and microvesicles.

  In addition to difficulties in detection and isolation of exosomes, the existence of various classification systems for exosomes and resulting lack of consensus among investigators regarding which method should be used for purification of the extracellular vesicles to be called "exosomes" make interpretation of experimental data and confirmation of reproducibility difficult. To overcome such situation, the International Society for Extracellular Vesicles (ISEV) has recently been established to nurture a global community of EV researchers and "Minimal Information for Studies of EVs" (MISEV) Guidelines has been published as international standard that investigators who intend to start EV research should consult.18, 19) In addition, as a method for avoiding such confusion, EV-TRACK knowledge database has been constructed to record experimental conditions employed in individual EV-related articles.20) On the other hand, as EV research has attracted global research interest, a number of large-scale research projects have been launched in various countries. In the United States, National Health Institute (NIH) has initiated a strategic large-scale project "Extracellular RNA Communication" and special interest groups on EV research have been organized at prestigious international conferences such as Gordon Conference and Keystone Symposia since 2016. In Europe, research covering EV has already been conducted as a part of CANCER-ID project supported by "Innovative Medicines Initiative (IMI)," a public-private partnership (PPP) for research and development of medicines. In Japan, EV research has been selected as one of the Research and Development Strategic Objectives in 2017 established by the Ministry of Education, Culture, Sports, Science and Technology Japan and acceleration of future research in this field is expected. In any case, development of solid research methodologies and techniques that constitute the basis of EV research is essentially required for future advancement in this research field, and we expect that the Tim4-affinity method will grow up to be one such technique.

References
  1. Kowal, J. et al. : Proc. Natl. Acad. Sci. USA, 113 (8), E968-977 (2016).
  2. Colombo, M., Raposo, G. and Thery, C. : Annu. Rev. Cell Dev. Biol., 30, 255-289 (2014).
  3. Bobrie, A., Colombo, M., Raposo, G. and Thery, C. : Traffic, 12 (12), 1659-1668 (2011).
  4. Bahrini, I., Song, J. H., Diez, D. and Hanayama, R. : Sci. Rep., 5, 7989 (2015).
  5. Kramer-Albers, E. M. and Hill, A. F. : Curr. Opin. Neurobiol., 39, 101-107 (2016).
  6. Tkach, M. and Thery, C. : Cell , 164 (6), 1226-1232 (2016).
  7. Hoshino, A. et al. : Nature, 527 (7578), 329-335 (2015).
  8. Thomou, T. et al. : Nature, 542 (7642), 450-455 (2017).
  9. Izquierdo-Useros, N., Puertas, M. C., Borras, F. E., Blanco, J. and Martinez-Picado, J. : Cell. Microbiol., 13(1), 10-17 (2011).
  10. Regev-Rudzki, N. et al. : Cell, 153 (5), 1120-1133 (2013).
  11. Valadi, H. et al. : Nat. Cell Biol., 9 (6), 654-659 (2007).
  12. Geiger, A., Walker, A. and Nissen, E. : Biochem. Biophys. Res. Commun., 467 (2), 303-309 (2015).
  13. Bell, B. M., Kirk, I. D., Hiltbrunner, S., Gabrielsson, S. and Bultema, J. J. : Nanomedicine, 12 (1), 163-169 (2016).
  14. Zhang, H. G. et al. : J. Immunol., 176 (12), 7385-7393 (2006).
  15. Batrakova, E. V. and Kim, M. S. : J. Control. Release, 219, 396-405 (2015).
  16. Thind, A. and Wilson, C. : J. Extracell. Vesicles, 5, 31292 (2016).
  17. Nakai, W. et al. : Sci. Rep., 6, 33935 (2016).
  18. Witwer, K. W. et al. : J. Extracell. Vesicles, 2 (2013).
  19. Lotvall, J. et al. : J. Extracell. Vesicles , 3, 26913 (2014).
  20. EV-TRACK Consortium, Van Deun, J. et al. : Nat. Methods, 14 (3), 228-232 (2017).

Resources

Posters and presentation materials that we have presented are here.
If you want to see other review articles and technical reports, please see Wako blog.

▼ Poster
Title Conference Year Language Data
A novel affinity-based method for the isolation of highly purified extracellular vesicles International Society for Extracellular Vesicles etc. 2017 English PDF
Flow cytometry of exosomes using the PS affinity method Consortium of Biological Science 2017 (ConBio2017) 2017 Japanese PDF
Development of high sensitive Exosome ELISA by using PS affinity Consortium of Biological Science 2017 (ConBio2017) 2017 English PDF
Characteristics of PS-affinity method for isolation and detection of EVs International Society for Extracellular Vesicles etc. 2018 English PDF
A novel affinity-based method for isolation and quantification of extracellular vesicles International Society for Extracellular Vesicles 2019 English PDF
▼ Presentation
Title Conference Year Language Data
Characteristics on PS Affinity for Isolation and Detection of EVs: Advantages Clarified from Comparison with Conventional Methods German Society for Extracellular Vesicles etc. 2019 English PDF
Novel extracellular vesicle purification technology - PS affinity method - Congress of the Japanese Society for Regenerative Medicine 2020 Japanese PDF
Purification of highly active MSC-derived extracellular vesicles realized by PS affinity method Japanese Society for Extracellular Vesicles 2020 Japanese PDF
▼ Movie
Movie Title Language Data
How to purify exosomes/EVs - Outline of Procedure of MagCapture Exosome Isolation Kit PS Ver.2 (Youtube 7:48) English Youtube

* Unauthorized copying and replication of the contents of this site, text and images are strictly prohibited.
The information written in this resources are as of the date presented.

Banner_ExosomeSpecialContents.png

Exosome_Application_Note_img01.png

Exosome_Technical_Report_img01.png

For research use or further manufacturing use only. Not for use in diagnostic procedures.

Product content may differ from the actual image due to minor specification changes etc.

If the revision of product standards and packaging standards has been made, there is a case where the actual product specifications and images are different.

877-714-1920

Hours of Operation: 8:00 - 17:00 (EST)For other hours than the above, please contact us via the inquiry form.